Professor Bart Currie
Director, RHDAustralia; Team leader, Tropical and Emerging Infectious Diseases
Bachelor of Medicine and Bachelor of Surgery, University of Melbourne, 1978; Fellow, Royal Australasian College of Physicians, 1985; Fellow of the Australian Faculty of Public Health Medicine, Royal Australasian College of Physicians, 1990; Diploma of Tropical Medicine and Hygiene, London School of Tropical Medicine and Hygiene, 1985.
On moving to Darwin more than 25 years ago, Professor Currie was initially head of the Menzies Clinical Division and now leads the Tropical and Emerging Infectious Diseases team within the Global and Tropical Health Division. Concurrently, Prof. Currie is also an infectious diseases physician at the Royal Darwin Hospital and since 2000 Professor in Medicine at the Northern Territory Medical Program, Flinders University. He is also Adjunct Professorial Fellow, Charles Darwin University and Adjunct Professor, College of Public Health, Medical and Veterinary Sciences, James Cook University. In late 2012 he took over as director of RHDAustralia, based at Menzies.
Prof. Currie’s passion is in coordinating links between clinicians, public health colleagues and other service providers, laboratory scientists and community.
The research Prof. Currie has been involved in has targeted improving prevention and treatment of specific illnesses usually through a better understanding of the underlying disease processes.
Prof. Currie was head of the Biomedical Program of the former Cooperative Research Centre (CRC) for Aboriginal and Tropical Health and an initial program leader of the Biomedical Program of the subsequent CRC for Aboriginal Health. Collaborations across Central and Northern Australia and with clinical and scientific colleagues elsewhere in Australia and overseas have resulted in 530 peer-reviewed publications.
Prof. Currie has peer reviewed grants for the NHMRC since the 1990s and has peer reviewed for 48 journals, including The Lancet, The New England Journal of Medicine and a range of PLoS and BMC open access journals.
Prof. Currie has supervised 16 successfully completed PhDs and 7 Master by Research students.
- A randomised controlled trial of alternative treatments to intramuscular penicillin for impetigo in Aboriginal children
- Darwin Prospective Melioidosis Study (D.P.M.S)
- Linking genomics of Burkholderia pseudomallei to melioidosis: diversity of clinical manifestations, changing epidemiology and microevolution in chronic carriage
- Characterisation of Burkholderia pseudomallei using unique genomic components
- The melioidosis agent Burkholderia pseudomallei in the anthropogenic environment of Northern Australia
- Melioidosis in Malaysian Borneo
- Burkholderia pseudomallei in Australia: A perspective of distribution and source attribution
- Diversity and virulence determinants among 1000 clinical and environmental isolates of Burkholderia pseudomallei
- False positives in the diagnosis of sexually transmitted Chlamydia trachomatis infection in children
- Combination antibiotic treatment for methicillin-resistant Staphylococcus aureus
- Beating scabies and strongyloides in Galiwin’ku.
- Wiersinga, W. J., Currie, B. J., & Peacock, S. J. (2012). Medical progress: Melioidosis. New England Journal of Medicine, 367(11), 1035-1044.
- Parameswaran, U., Baird, R. W., Ward, L. M., & Currie, B. J. (2012). Melioidosis at royal darwin hospital in the big 2009-2010 wet season: Comparison with the preceding 20 years. Medical Journal of Australia, 196(5), 345-348.
- Currie, B. J., Ward, L., & Cheng, A. C. (2010). The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year darwin prospective study. PLoS Neglected Tropical Diseases, 4(11).
- Currie, B. J., & McCarthy, J. S. (2010). Permethrin and ivermectin for scabies. New England Journal of Medicine, 362(8), 717-725.
- Currie, B. J., Haslem, A., Pearson, T., Hornstra, H., Leadem, B., Mayo, M., et al. (2009). Identification of melioidosis outbreak by multilocus variable number tandem repeat analysis. Emerging Infectious Diseases, 15(2), 169-174.
- Currie, B. J. (2006). Group A streptococcal infections of the skin: Molecular advances but limited therapeutic progress. Current Opinion in Infectious Diseases, 19(2), 132-138.
- Currie, B. J. (2006). Treatment of snakebite in Australia: The current evidence base and questions requiring collaborative multicentre prospective studies. Toxicon, 48(7), 941-956.
- McDonald, M., Currie, B. J., & Carapetis, J. R. (2004). Acute rheumatic fever: A chink in the chain that links the heart to the throat? Lancet Infectious Diseases, 4(4), 240-245.
- Currie, B. J., Harumal, P., McKinnon, M., & Walton, S. F. (2004). First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 39(1), e8-12.
- Currie, B. J. (2004). Snakebite in tropical Australia: A prospective study in the "top end" of the Northern Territory. Medical Journal of Australia, 181(11-12), 693-697.
Click here to view more Bart Currie publications in PubMed.
The Menzies School of Health Research (Menzies) has been awarded federal funding for 12 competitive grants and fellowships to help improve outcomes for disadvantaged populations in Australia and the Asia- Pacific region.
A potentially fatal bacterial disease, lurking in soil.
Life in northern Australia is full of spectacular surprises and natural hazards, some more obvious than others.
A Menzies project has been recognised amongst the nationís premier research projects by Australiaís peak body for health and medical research.
In a world-first study, treatment of a whole community with oral ivermectin has been shown to virtually eliminate scabies, providing new hope in the fight to control this debilitating disease.
A NEW trial that reduced scabies outbreaks by 94 per cent in one year could hold the key to its prevention in indigenous communities in the Territory.
The bacterium Burkholderia pseudomallei is found in soil and water and causes the disease melioidosis in humans and animals. It was upgraded to a Tier 1 Select Agent by the US Centers for Disease Control and Prevention in 2012 ó the designation given to pathogens considered of highest risk.
Work will begin to help close critical gaps in healthcare across northern Australia as the result of a $6m grant awarded today to Menzies School of Health Research (Menzies) by the National Health and Medical Research Council (NHMRC).